Stocks of Abbott Laboratories - Current price, Where to buy? Dividends
| Detail | Data |
|---|---|
| Stocks: | Abbott Laboratories |
| ompany Name: | Abbott Laboratories |
| Ticker: | ABT |
| Exchange: | NYSE |
| Outstanding stocks: | 1,735,180,032 |
| 24-hour Volume: | 3,546,864 |
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Number of Employees: | 114000 |
| Country: | United States |
| City: | North Chicago |
| Address: | 100 Abbott Park Road |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 32.99 | 20.60 | 3.21 USD | 5.14 USD | 22.26 USD | 183,790,272,512.00 USD |
| P/E Ratio: | 32.99 |
|---|---|
| Forward P/E: | 20.60 |
| EPS: | 3.21 USD |
| Forward EPS: | 5.14 |
| Book value per share: | 22.26 USD |
| Market capitalization: | 183,790,272,512.00 USD |
Abbott Laboratories
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 40,326,000,640.00 USD |
| Net Income: | 5,608,000,000.00 USD |
| Price-to-Book (P/B) Ratio: | 4.76 |
| PEG Ratio: | 2.82 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for Abbott Laboratories stocks is: buy |
| Number of Analysts: | 20 |
| Highest Target Price: | 143 USD |
| Lowest Target Price: | 107 USD |
| Average Target Price: | 126.5 USD |
Note: The data is approximate. Recommendations and price forecasts for Abbott Laboratories stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | Company Abbott Laboratories pays a dividend of 2.2 USD per share. |
| Annual Yield %: | 2.08 % |
| Ex-dividend Date: | 2024-04-12 |
| Average % Yield for 5 Years: | 1.6 % |
| Payout Ratio: | 64.8 % |
| Value of Last Dividend Paid: | 0.55 USD |
| Date of Last Dividend: | 2024-04-12 |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Abbott Laboratories Stocks?
If you're interested in investing in Abbott Laboratories stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Abbott Laboratories stocks through mobile apps with client support. In this table, you can compare brokers offering real Abbott Laboratories stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Abbott Laboratories (ABT)
Abbott Laboratories consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 40,326,000,640.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 10,344,750,080.00 USD, Abbott Laboratories maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.41 suggests that Abbott Laboratories has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 55.28% shows that Abbott Laboratories efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of 13.96% suggests opportunities for Abbott Laboratories to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 40,326,000,640.00 USD |
| EBITDA: | 10,344,750,080.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 3.21 USD |
| Book Value Per Share: | 22.26 USD |
| Total Cash: | 7,279,000,064.00 USD |
| Total Cash per Share: | 4.20 USD |
| Total Debt: | 15,873,000,448.00 USD |
| Debt to Equity Ratio: | 0.41 |
| Quick Ratio: | / |
| Current Ratio: | / |
| Free Cash Flow: | / |
| Operating Cash Flow: | / |
| Company Margins | |
| Gross Margins: | 55.28 % |
| EBITDA Margins: | 25.65 % |
| Operating Margins: | 14.06 % |
| Profit Margins: | 13.96 % |
| Performance | |
| Return on Assets: | / |
| Return on Equity: | / |
| Earnings Growth (1 year): | -6.7% |
| Revenue Growth (1 year): | 2.2 % |
| Year-over-Year Quarterly Earnings Growth: | -7.1 % |
| Valuation | |
| Market Capitalization: | 183,790,272,512.00 USD |
| Enterprise Value: | 192,574,013,440.00 USD |
| EV/Revenue: | 4.775 |
| EV/EBITDA: | 18.616 |
| Number of Shares and Short Shares | |
| Float Shares: | 1,723,853,536 shares |
| Shares Outstanding: | 1,739,629,952 shares |
| Held Percent Insiders: | 0.01 % |
| Held Percent Institutions: | 76.59 % |
| Shares Short: | 12,937,099 |
| Shares Short Prior Month: | 15,715,789 |
| Date Short Interest: | 2024-04-15 |
| Shares Percent Shares Out: | 0.75 % |
| Short Ratio: | 1.88 |
| Beta: | 0.74 |
| Short Percent of Float: | 0.75 % |
| Předpokládaný počet akcií: | 1,735,180,032 |
Frequently Asked Questions (FAQ)
The company Abbott Laboratories pays a dividend of 2.2 USD per share. At this rate, the annual yield is 2.08 %.
Abbott Laboratories shares are traded on the stock exchange NYSE under the ticker symbol: ABT. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for Abbott Laboratories shares by a total of 20 analysts. The average target price prediction is 126.5 USD per share.
The total number of Abbott Laboratories shares on the exchange is 1,739,629,952.00, which, at the current market capitalization, values the company at 183,790,272,512.00 USD.
